Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Measuring brain atrophy. What can be done and where are we heading?

Falling chronically ill – How do I cope and move forward?

Cognitive decline – The invisible burden of MS?

Lp(a) as ASCVD risk factor

Cognitive training – A curse or a blessing?

PCSK9 Inhibitors in Real World Practice

How old is your brain?

The role and importance of Patients Associations and Scientific societies ; UAE experience

Exercise as ”medicine” in the treatment of MS

Understanding Ttp

TTP is a life-threatening thrombotic microangiopathy (TMA) that requires quick diagnosis and urgent treatment. 1,2

A promising biomarker in MS: Neurofilament light chain

PCSK9i and Prevention of CVD

The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.